DNLI - Citi starts Denali at buy sees catalyst-rich window starting in 2024
2023-12-13 15:23:21 ET
More on Denali Therapeutics
- Diving Into Denali Therapeutics
- Denali's New Summit: Changing Hunter Syndrome Landscape
- JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower
- Seeking Alpha’s Quant Rating on Denali Therapeutics
- Historical earnings data for Denali Therapeutics
For further details see:
Citi starts Denali at buy, sees catalyst-rich window starting in 2024